Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

@ipwatchdog
ipwatchdog.com > sessions > evolving-life-sciences-ip-rulebook

The Evolving Life Sciences IP Rulebook: Tracking Congress, the USPTO and FDA

15+ hour, 57+ min ago   (226+ words) The rules governing life sciences innovation are increasingly being shaped across multiple fronts. Congress continues to consider legislation affecting patents and biopharmaceutical competition, while the USPTO and FDA are pursuing policies and initiatives that can materially alter patent protection, regulatory…...

The Hawk
thehawk.in > news > science > watching-cancer-cells-live-could-transform-drug-discovery

Watching cancer cells live could transform drug discovery

2+ hour, 4+ min ago   (276+ words) New Delhi, Aug 8 (IANS) A platform that lets researchers observe living cells on a continuous basis could transform drug discovery, reshape cancer research and precision medicine, according to experts on Saturday. Dr. Shyam Aggarwal, Chairperson, Department of Medical Oncology at…...

The Clinical Trial Vanguard
clinicaltrialvanguard.com > opinion > ai-drug-discovery-has-8-9-billion-in-hype-and-zero-fda-approvals-when-does-the-bill-come-due

AI Drug Discovery Has $8.9 Billion in Hype and Zero FDA Approvals: When Does the Bill Come Due?

5+ hour, 18+ min ago   (232+ words) The consensus narrative, then, is one of arrival. AI has moved from theoretical to operational, and the only remaining question is execution speed. Yet as of August 2026, not a single AI-discovered drug holds full FDA approval. Projections for the first…...

Big News Network.com
bignewsnetwork.com > news > 27/92/27004 > ai-becoming-core-infrastructure-for-pharmaceutical-rd-not-just-an-experimental-tool-report

AI becoming core infrastructure for pharmaceutical R&D, not just an experimental tool: Report

11+ hour, 16+ min ago   (455+ words) ANI 8th August 2026, 12:30 GMT+11 New Delhi [India], August 8 (ANI): Artificial intelligence (AI) is rapidly becoming a core part of pharmaceutical research and development (R&D), moving beyond its role as an experimental technology to help companies accelerate drug discovery, improve research productivity…...

Drug Discovery News
drugdiscoverynews.com > accelerating-organoid-research-with-high-content-imaging-17419

Accelerating organoid research with high-content imaging

15+ hour, 35+ min ago   (140+ words) Drug Discovery News Accelerating organoid research with high-content imaging Advances in automated imaging are expanding the scalability of organoid phenotyping workflows. Imaging and quantitatively analyzing organoids at scale remains challenging because conventional microscopy workflows are time intensive, while alternative methods…...

Free Press Journal
freepressjournal.in > indore > international-conference-on-ai-driven-drug-development-begins-in-indore

International Conference On AI-Driven Drug Development Begins In Indore

9+ hour ago   (49+ words) An international conference on AI-enabled drug development began at Indore Institute of Pharmacy in collaboration with Biovance Solutions, UK. Experts from academia, industry and regulatory bodies discussed artificial intelligence in drug discovery, clinical research, regulatory science and patient safety, highlighting…...

BIOENGINEER.ORG
bioengineer.org > neutrophil-released-s100a8-a9-activates-reparative-macrophages-delaying-denervated-muscle-atrophy

Neutrophil-Released S100A8/A9 Activates Reparative Macrophages, Delaying

5+ hour, 39+ min ago   (451+ words) A newly reported immune mechanism may help explain why muscles waste away after losing their nerve supply—and why the body’s own early inflammatory response could also slow that decline....

@ipwatchdog
ipwatchdog.com > sessions > biopharmaceutical-innovation-happens

From Molecule to Medicine: How Biopharmaceutical Innovation Actually Happens

15+ hour, 57+ min ago   (295+ words) Public debates about pharmaceutical patents often assume that the principal act of innovation is discovering or identifying a new active ingredient, and what follows is little more than routine execution. The reality of developing a medicine is considerably more complicated....

DEV Community
dev.to > multigrid > ai-in-drug-discovery-what-a-model-can-move-and-what-it-cannot-2pfn

AI in Drug Discovery: What a Model Can Move and What It Cannot

14+ hour, 55+ min ago   (339+ words) This page is about method, not about any particular medicine, and nothing here is medical advice. It is written to answer one question: when a company says a drug was discovered with AI, which part of a decade-long process is…...

@ipwatchdog
ipwatchdog.com > sessions > uspto-life-sciences-patent-applicants

Inside the USPTO: What Life Sciences Patent Applicants Need to Know

20+ hour, 32+ min ago   (214+ words) Patent law establishes the substantive rules for examination, but the prosecution experience is also shaped by what happens inside the USPTO—examiner workloads and incentives, pendency, internal management, quality initiatives, training, examination guidance and the tools available to the examining…...